HBOT for Stroke: Cost, Insurance, and Medicare Coverage

Understanding HBOT costs and insurance coverage for stroke patients

How we evaluate: Our recommendations are based on published clinical evidence, manufacturer specifications, and real user feedback. We may earn a commission if you purchase through our links, at no extra cost to you. This does not influence our rankings.
Full disclosure.

Hyperbaric Oxygen Therapy (HBOT) for stroke recovery is not covered by Medicare or most private insurers. Stroke is not among the 15 conditions Medicare covers for HBOT. Out-of-pocket costs for a standard 40-session protocol range from $6,000 to $20,000 depending on the facility type. This article breaks down the actual costs, the few exceptions where coverage may apply, and how to navigate the financial side of HBOT for stroke.

Evidence Strength: Insurance & Cost Data for Stroke HBOT
Medicare Coverage (Not Covered)

Strong
Clinical Trial Access

Moderate
Future Coverage Prospects

Emerging

Why Medicare Does Not Cover HBOT for Stroke

Medicare Part B covers HBOT for 15 specific medical conditions. These include diabetic foot ulcers (Wagner grade III or higher), radiation necrosis, gas gangrene, decompression sickness, carbon monoxide poisoning, compromised skin grafts, and chronic refractory osteomyelitis, among others.

15
Specific conditions Medicare covers for HBOT. Stroke is not one of them.
CMS National Coverage Determination 20.29

Stroke is not on the list. Neither acute stroke nor chronic stroke recovery qualifies for Medicare HBOT coverage under CMS National Coverage Determination 20.29. The reason: the Cochrane Review and other systematic reviews concluded that evidence is insufficient to support HBOT as a standard treatment for stroke. Until that evidence standard changes, Medicare will not cover it.

This means that stroke patients seeking HBOT will pay entirely out of pocket in most cases.

What HBOT for Stroke Actually Costs

The cost varies substantially depending on where you receive treatment. Here are the current ranges based on facility type in the United States:

Per-Session Costs by Facility Type

  • Independent clinic, standard pressure (1.5 to 2.0 ATA): $150 to $250 per session. This is the most common setting for off-label HBOT.
  • Independent clinic, high pressure (2.0 to 3.0 ATA): $250 to $500+ per session. Physician-supervised, clinical-grade protocols.
  • Hospital outpatient: $400 to $650 per session. Hospital billing infrastructure adds overhead.
  • Hospital (billed through facility): $1,000 to $2,500 per session. This includes facility fees, physician fees, and hospital overhead. This is the cost structure that applies when HBOT is covered by insurance for approved indications.

Total Cost for a Standard 40-Session Protocol

The most studied stroke HBOT protocol involves 40 sessions at 2.0 ATA (atmospheres absolute), 90 minutes per session, five days per week. Based on the per-session costs above:

  • Independent clinic (mid-range): $6,000 to $10,000 total
  • Independent clinic (high-end): $10,000 to $20,000 total
  • Hospital outpatient: $16,000 to $26,000 total

Many independent clinics offer package pricing that reduces the per-session cost. A typical discount structure might look like: 5% off for 10 sessions, 10% off for 20 sessions, 15% off for 40 sessions. Some clinics offer membership models at $350 to $650 per month for 3 to 6 sessions. For a deep dive into pricing, see our full HBOT cost guide.

$6,000-$20,000
Out-of-pocket cost for a 40-session stroke HBOT protocol at U.S. clinics
Independent and hospital-based HBOT clinic pricing, 2026

Private Insurance: Same Story, Different Letterhead

Most private insurance companies follow Medicare’s coverage criteria. UnitedHealthcare, Aetna, Cigna, and Blue Cross Blue Shield all maintain medical policies that restrict HBOT coverage to the same approved conditions list.

Stroke is explicitly excluded from coverage by all major private insurers. The typical policy language classifies HBOT for stroke as “investigational” or “experimental” and denies claims on that basis.

There is one narrow exception worth understanding.

The Wound Complication Exception

If a stroke patient develops a secondary wound complication that independently qualifies for HBOT coverage, the HBOT may be covered for that specific indication. The most common scenario:

  • A stroke patient who is immobilized develops a diabetic foot ulcer (Wagner grade III or higher) that fails standard wound therapy. This wound, not the stroke, qualifies for Medicare or private insurance HBOT coverage.
  • A stroke patient who undergoes surgery and develops a compromised skin graft or flap may qualify for HBOT coverage related to the surgical complication.

In these cases, the HBOT sessions are approved for the wound, not the stroke. However, the brain benefits of HBOT may still occur as an incidental effect of the treatment. This is a narrow exception, not a reliable pathway, but it is worth discussing with your provider if applicable.

Appealing an Insurance Denial

If you have already received an HBOT denial and want to appeal, here is the general process:

  • Step 1: Get the denial in writing. Request the specific policy language and medical criteria used to deny the claim.
  • Step 2: Gather supporting documentation. This includes your neurologist’s letter of medical necessity, relevant published studies (the Efrati 2013 RCT and Hadanny 2020 study are the strongest), and any brain imaging showing recoverable penumbral tissue.
  • Step 3: File a formal appeal. Most insurers allow at least two levels of internal appeal. After exhausting internal appeals, you can request an external review by an independent reviewer.
  • Step 4: Be realistic. Appeals for off-label HBOT uses have a very low success rate. The evidence base, while promising, does not meet the threshold that insurers require for coverage approval.

Some patients have reported success with appeals when they can demonstrate that conventional rehabilitation has been exhausted and that imaging shows recoverable brain tissue. But this is the exception, not the rule.

What Do Clinical Studies Show?

One way to access HBOT for stroke at reduced or no cost is through clinical trials. Researchers are actively studying HBOT for chronic stroke recovery, and participation often includes the treatment at no charge.

To find active trials, search ClinicalTrials.gov for “hyperbaric oxygen” and “stroke”. As of 2026, there are ongoing and upcoming trials examining HBOT for chronic stroke recovery, including sham-controlled designs that will help strengthen the evidence base.

The trade-off: clinical trials involve randomization (you may receive sham treatment), specific inclusion/exclusion criteria, and time commitments for follow-up assessments. But for patients who qualify, this is the most accessible path to HBOT for stroke at no direct cost.

Hospital vs. Independent Clinic: Where to Go

For stroke patients paying out of pocket, independent HBOT clinics are typically the most cost-effective option. Here is how they compare:

  • Hospital outpatient: Higher cost ($400 to $650+/session), but may have neurologist on staff, integrated medical records, and emergency backup. Best for patients with complex medical histories or recent strokes.
  • Independent HBOT clinic: Lower cost ($150 to $300/session), often more flexible scheduling, and typically experienced with off-label protocols. Best for chronic stroke patients who are medically stable.
  • Soft chamber/wellness centers: Lowest cost ($50 to $100/session), but these operate at 1.3 ATA with ambient air. The clinical studies showing benefit in stroke patients used hard chambers at 2.0 ATA with 100% medical-grade oxygen. Soft chambers have not been validated for stroke recovery in published research.

If you are considering HBOT specifically for stroke recovery, a hard chamber operating at 2.0 ATA with 100% oxygen is what the evidence supports. For more details on what to expect during treatment, see our HBOT insurance coverage guide.

Financing Options

Several options exist for managing the out-of-pocket cost:

  • HSA/FSA funds: Health Savings Accounts and Flexible Spending Accounts can sometimes be used for HBOT when prescribed by a physician. Check with your plan administrator.
  • Payment plans: Many independent clinics offer monthly payment plans for multi-session packages.
  • Medical financing: Companies like CareCredit and Prosper Healthcare Lending offer medical loans specifically for treatments not covered by insurance.
  • Clinic discounts: Negotiating directly with clinics, especially for a full 40-session package, can yield 10 to 20% discounts.

Tricare, Medicaid, and VA Coverage

Three other coverage pathways are worth exploring for specific patient populations.

Tricare (Military)

Tricare generally follows Medicare coverage criteria for HBOT. This means stroke is not a covered indication. However, veterans with service-connected injuries that independently qualify for HBOT (such as radiation injuries from military exposure, or wounds from combat) may receive HBOT that incidentally benefits stroke-related deficits.

Medicaid

Medicaid coverage varies by state. Some state Medicaid programs cover HBOT for approved indications similar to Medicare’s list. Stroke is not a covered indication in any state Medicaid program as of 2026. However, coverage policies vary, and it is worth contacting your state’s Medicaid office directly to confirm current rules.

VA Health System

The Department of Veterans Affairs provides HBOT at some VA medical centers for approved indications. For off-label uses like stroke recovery, coverage depends on individual clinical assessment and facility availability. Some VA centers have participated in HBOT research studies, which can provide access for qualifying veterans at no cost.

Veterans with both stroke history and a qualifying wound condition (such as diabetic foot ulcers) may be able to access HBOT through the VA for the wound, potentially gaining neurological benefits as well.

Travel and Accommodation Costs

An often-overlooked expense is the cost of getting to and from treatment. The standard HBOT protocol for stroke involves 40 sessions, five days per week for eight weeks. If the nearest qualified HBOT clinic is not in your area, the logistics add up:

  • Local patients: Gas, parking, and time costs for 40 round trips. Depending on distance, this could add $200 to $500 over the course of treatment.
  • Regional travel: If the nearest hard-chamber HBOT clinic is 1 to 3 hours away, patients may need to relocate temporarily. Eight weeks in a hotel or short-term rental can cost $3,000 to $8,000 depending on the area.
  • Caregiver costs: Stroke patients often need a caregiver to drive them to appointments, especially in the early weeks of treatment. If the caregiver takes time off work, the lost income should be factored into the total cost.

Some HBOT clinics in areas with high concentrations of off-label patients (such as south Florida, parts of Texas, and California) have developed relationships with nearby hotels or extended-stay facilities that offer medical stay discounts. Ask the clinic about these arrangements before booking independently.

Cost Comparison: HBOT vs. Other Post-Stroke Interventions

To put HBOT costs in context, here is how they compare to other interventions stroke patients may pursue:

  • Inpatient rehabilitation (30 days): $20,000 to $50,000+ depending on facility and insurance.
  • Outpatient physical therapy (3 months, 3x/week): $2,000 to $6,000 with insurance copays; $5,000 to $15,000 without insurance.
  • Robotic-assisted therapy (20 sessions): $4,000 to $10,000, typically not covered by insurance.
  • HBOT (40 sessions at independent clinic): $6,000 to $12,000 out of pocket.
  • Transcranial magnetic stimulation (TMS, 20-30 sessions): $6,000 to $12,000, limited insurance coverage for stroke.

HBOT is in a similar cost range to other adjunctive post-stroke therapies. The difference is that HBOT has published RCT data showing cognitive improvements in chronic stroke (Efrati 2013), while some competing interventions have a thinner evidence base for the chronic phase.

What Could Change Coverage in the Future

Medicare coverage decisions are driven by evidence. The current barrier is the lack of large, multi-site, sham-controlled randomized trials demonstrating HBOT efficacy for stroke. Most positive data comes from a single research center (the Sagol Center in Israel).

If ongoing and future trials (including the Harrison 2024 sham-controlled trial and others in development) produce strong positive results, this could shift the evidence landscape enough to trigger a coverage review. The Undersea and Hyperbaric Medical Society (UHMS) and other professional bodies would need to update their recommendations, and CMS would need to revise NCD 20.29.

This is unlikely to happen in the near term (1 to 2 years) but is plausible over a 5 to 10 year horizon if the research continues to trend positive.

A Cost-Benefit Perspective

The financial burden of HBOT for stroke is real. But it is worth contextualizing against the broader costs of stroke recovery. The average lifetime cost of stroke in the United States exceeds $100,000 per patient when accounting for acute care, rehabilitation, lost productivity, and long-term care. For severe strokes, costs can exceed $500,000.

$100,000+
Average lifetime cost of stroke per patient in the U.S., putting HBOT cost in perspective
U.S. stroke cost estimates

A 40-session HBOT protocol at $6,000 to $12,000 represents a modest investment relative to those figures, particularly if it produces meaningful improvements in cognitive function or independence that reduce long-term care needs. The published recovery statistics can help you weigh whether the potential benefits justify the cost for your specific situation.

Sources

  1. Medicare.gov. “Hyperbaric Oxygen Therapy Coverage.” medicare.gov/coverage/hyperbaric-oxygen-therapy. Verified March 2026.
  2. CMS. “NCD – Hyperbaric Oxygen Therapy (20.29).” cms.gov. Verified May 2026.
  3. Gelly HB, Fife CE, Walker D, Eckert KA. “Trends in Medicare Costs of Hyperbaric Oxygen Therapy, 2013 through 2022.” Undersea & Hyperbaric Medicine. 2024. DOI: 10.22462/702
  4. Efrati S, et al. “Hyperbaric Oxygen Induces Late Neuroplasticity in Post Stroke Patients.” PLoS ONE. 2013;8(1):e53716. DOI: 10.1371/journal.pone.0053716
  5. Hadanny A, et al. “Hyperbaric oxygen therapy improves neurocognitive functions of post-stroke patients.” Restorative Neurology and Neuroscience. 2020;38(1):93-108.
  6. Bennett MH, et al. “Hyperbaric oxygen therapy for acute ischaemic stroke.” Cochrane Database of Systematic Reviews. 2014;(11):CD004954. DOI: 10.1002/14651858.CD004954.pub3
  7. UHMS. “2025 CMS Payment Update Highlights.” uhms.org. 2025.
  8. UnitedHealthcare. “Hyperbaric Oxygen Therapy and Topical Oxygen Therapy.” Medical policy. uhcprovider.com. Verified May 2026.

Medical Disclaimer

The content on BaricBoost.com is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Seph Fontane Pennock

Seph Fontane Pennock

Author

Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.

Website

Previous Article

HBOT and Neuroplasticity After Stroke: How Oxygen Rebuilds the Brain

Next Article

HBOT for Ischemic vs Hemorrhagic Stroke: Does the Type Matter?

Write a Comment

Leave a Comment

Your email address will not be published. Required fields are marked *

One Email a Week.
Better Health Decisions.

Weekly breakdowns of the latest HBOT, ozone therapy, and oxygen therapy research. Clinical insights, treatment protocols, and evidence-based guidance for patients and practitioners.
Trusted by patients, clinicians, and researchers worldwide